HRMY vs QQQ Stock Comparison

HRMY currently leads QQQ in this stock comparison, with AIQ scores of 73 vs 46. The clearest difference is value, while QQQ has the stronger quality profile.

Market data as of Nov 15, 2026 market close· AIQ score gap 27 points
HRMY
Healthcare
vs
QQQ
Equity
HRMY
Harmony Biosciences Holdings, Inc.
Leads
Price
$33.76
Day move
-0.12%
AIQ Score
73/100
Best edge
Value
Sector
Healthcare
QQQ
Invesco QQQ Trust, Series 1
Price
$680
Day move
-1.2%
AIQ Score
46/100
Best edge
Quality
Sector
Equity

What is the main difference between HRMY and QQQ?

HRMY leads the current stock comparison as Harmony Biosciences Holdings, Inc., with the clearest separation coming from value and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Harmony Biosciences Holdings, Inc. vs Invesco QQQ Trust, Series 1

Data as of Nov 15, 2026· market close· HRMY (stock) vs QQQ (ETF)· Coverage 65/66 fields· 42/42 directly comparable· Moderate confidence
AIQ VerdictStableAIQ Comparison Conviction 9/10

HRMY leads

HRMY leads by 27 AIQ points, primarily on Value and Momentum, and the lead has widened from 17 points over 30 sessions.

Stable: 3 of 4 evidence groups support HRMY, its lead is widening, and its signal state is cleanly positive.

Evidence agreement: 3 of 4Comparison trend: Strengthening
HRMY

Harmony Biosciences Holdings, Inc.

Leads
AIQ Score
73/100
AIQ Edge Score
9/10
QQQ

Invesco QQQ Trust, Series 1

AIQ Score
46/100
AIQ Edge Score
4/10

The Algovestiq AIQ Score currently favors HRMY over QQQ, 73 versus 46 as of Nov 15, 2026. HRMY's advantage is driven primarily by stronger value and momentum, while QQQ holds the stronger quality profile. HRMY also shows the weaker technical structure relative to its 50-day moving average. 3 of 4 covered evidence groups favor HRMY today, and the comparison is rated Stable on stability. HRMY lead: Strengthening — the AIQ differential moved from 17 to 27 points over 30 sessions.

Compare Harmony Biosciences Holdings, Inc. and Invesco QQQ Trust, Series 1 across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Total return with distributions reinvested, from daily closes.

HRMY
-15.9%
QQQ
+76.1%

Total return comparison

Growth of $10,000, distributions reinvested

HRMY $8,413 · QQQ $17,615

Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.

Compare HRMY and QQQ against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

HRMY advantage
0
QQQ advantage
  • Value89 vs 13
    HRMY +76
  • Momentum66 vs 33
    HRMY +33
  • Risk Resilience63 vs 31
    HRMY +32
  • Quality77 vs 93
    QQQ +16

3 of 4 evidence groups favor HRMY. HRMY’s edge is concentrated in value and momentum; QQQ keeps a meaningful quality edge.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

HRMY0 AIQ

Largest factor move: Quality +1, not enough on its own to move the overall score.

No signal started or stopped since the prior session; its 3 active signals are unchanged.

QQQ-1 AIQ

Largest factor move: Value +1

New signals

  • Price Lost 200-Day MA — bearish, trend, long horizon
  • Drawdown Recovery Signal — bullish, risk_regime, long horizon (-14.8%)

HRMY's lead widened by 1 AIQ point in the latest session.

Deeper signal detail for each name lives on its own signals page — HRMY and QQQ both carry a full feed there.

The central trade-off

HRMY (Harmony Biosciences Holdings, Inc.): the stronger current systematic profile, led by value and momentum.

QQQ (Invesco QQQ Trust, Series 1): the counter-case, on quality, technicals.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

HRMY

HRMY on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

Even

Growth figures are not covered for both names.

Value

HRMY

HRMY on the peer-relative Value factor, by 76 points.

Momentum

HRMY

HRMY on the Momentum factor, by 33 points.

Lower downside

HRMY

HRMY on Risk Resilience, by 32 points.

Analyst upside

Even

Analyst targets are level or not covered for both names.

AIQ vs Wall Street

Where the systematic read and the analyst consensus line up — and where they do not.

MeasureHRMYQQQNote
Implied upside to target+52.5%—Level
Target dispersion+35%—Lower is tighter analyst agreement
ConsensusBuy—Context, not a primary driver
Analysts covering12—Higher coverage generally improves confidence

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

3 of 4 covered evidence groups favor HRMY. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreHRMY73 vs 46
FundamentalsNot coveredNot covered
ValuationHRMYValue 89 vs 13
TechnicalsQQQPrice vs 50-day -12.6% vs -5.3%; vs 200-day -2.4% vs -0.3%
Risk ResilienceHRMYRisk Resilience 63 vs 31
Analyst expectationsNot coveredNot covered

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of HRMY and QQQ and are excluded from the count.

AIQ Decision Stability

Stable

The conclusion rests on a wide gap and broad agreement. It is unlikely to turn on a single session.

  • The AIQ gap is wide at 27 points. (supports the conclusion holding)
  • The leader's advantage has been widening. (supports the conclusion holding)
  • The leader's signal state is cleanly positive. (supports the conclusion holding)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on HRMY.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

HRMY lead: Strengthening — the AIQ differential moved from 17 to 27 points over 30 sessions.

May 27HRMY leads above the line · QQQ leads belowNov 13
Today
HRMY +27
73 vs 46
7 sessions ago
HRMY +26
76 vs 50
30 sessions ago
HRMY +17
80 vs 63
90 sessions ago
HRMY +18
74 vs 56

The lead has not changed hands in this window.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

HRMY

1 bullish / 0 bearish / 2 neutral

Only HRMY

  • ADX Trend Strengthening — neutral, trend, medium horizon
  • ATR Expansion - Breakout Mode — neutral, volatility, short horizon (4.79%)
QQQConflicted

2 bullish / 1 bearish, conflicted

Only QQQ

  • Price Lost 200-Day MA — bearish, trend, long horizon
  • Drawdown Recovery Signal — bullish, risk_regime, long horizon (-14.8%)

Both carry 1 more signal that do not separate them: Golden Cross Active.

QQQ is conflicted, so the timing case there is weaker than the score alone suggests.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

HRMYNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -0.12%, AIQ 0 points).

QQQConfirmed weakness

Price and the AIQ Score both moved down over the latest session (price -1.2%, AIQ -1 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1QQQ closes the Value gap — currently 76 points behind, the largest single contributor to HRMY's edge.
  2. 2QQQ's Price Lost 200-Day MA resolves — a bearish trend rule currently active against it.
  3. 3HRMY's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict.
  4. 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

Split
MetricHRMYQQQ
Revenue growth (YoY)2.9%—
EPS growth (YoY)-36.2%—
Gross margin74%—
Operating margin22.2%—
Return on equity (TTM)4.5%—
Debt to equity0.14—

Performance

QQQ leads 5 of 6 windows
MetricHRMYQQQ
1 week (5 sessions)2%3.6%
1 month (20 sessions)-11%-4.2%
3 months (63 sessions)-11.5%-6.8%
6 months (126 sessions)12.2%-4.1%
Year to date-9.8%10.7%
1 year (252 sessions)0.7%9.5%

Technicals

QQQ has the stronger structure
MetricHRMYQQQ
RSI (14)36.442.8
ADX (14)34.730.3
Price vs 50-day-12.6%-5.3%
Price vs 200-day-2.4%-0.3%
Volatility (1M, annualized)46.4%35.4%

Risk

HRMY is the more resilient
MetricHRMYQQQ
Beta0.631.46
Sharpe ratio0.070.44
Sortino ratio0.090.62
Max drawdown-34.5%-14.8%
Current drawdown-21.2%-10.5%
Annualized volatility40.6%21.5%
Value at risk (95%)-3.9%-2%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, HRMY or QQQ?

On the Algovestiq AIQ Score, HRMY is the stronger of the two as of Nov 15, 2026, scoring 73 against QQQ's 46. The edge comes from value and momentum. QQQ is not without a case — it holds the better quality profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is HRMY or QQQ the better buy right now?

HRMY carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Stable — 3 of 4 covered evidence groups agree. A Stable rating means the gap is wide and the evidence is broad, so the conclusion is unlikely to turn on a single session.

Why does the AIQ Score favor HRMY over QQQ?

The composite weights Quality, Value, Momentum and Risk Resilience. HRMY leads Value by 76 points; HRMY leads Momentum by 33 points; HRMY leads Risk Resilience by 32 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, HRMY or QQQ?

Analyst price targets imply +52.5% upside for HRMY and not covered for QQQ. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, HRMY or QQQ?

HRMY is the better-valued of the two on the peer-relative Value factor. HRMY on the peer-relative Value factor, by 76 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, HRMY or QQQ?

Growth figures are not covered for both names. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, HRMY or QQQ?

HRMY on the Momentum factor, by 33 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, HRMY or QQQ?

HRMY is the more resilient of the two, so the other name carries the higher downside risk. HRMY on Risk Resilience, by 32 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is HRMY more profitable than QQQ?

Margin data is not comparable for both names in the current snapshot.

Is HRMY's lead over QQQ getting stronger or weaker?

HRMY lead: Strengthening — the AIQ differential moved from 17 to 27 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has not changed hands in that window.

What would change the HRMY vs QQQ verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: QQQ closes the Value gap — currently 76 points behind, the largest single contributor to HRMY's edge; QQQ's Price Lost 200-Day MA resolves — a bearish trend rule currently active against it; HRMY's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

What do the current signals say about HRMY and QQQ?

HRMY: 1 bullish / 0 bearish / 2 neutral. QQQ: 2 bullish / 1 bearish, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on HRMY is Golden Cross Active (bullish, long horizon). On QQQ it is Golden Cross Active (bullish, long horizon).

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.